Reducing Vertigo Associated With MRI Machines
Launched by JOHNS HOPKINS UNIVERSITY · Sep 25, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying ways to reduce feelings of dizziness and vertigo that some people experience when getting an MRI scan, especially with high-strength MRI machines. Researchers believe that these uncomfortable sensations happen because of a force affecting the inner ear when patients enter the strong magnetic field of the MRI. In this study, they will test whether entering and exiting the MRI machine more slowly—taking one, two, or three minutes instead of the usual 20 seconds—can help lessen these feelings of dizziness.
To be eligible for this trial, participants must be between the ages of 65 and 74 and scheduled for an MRI scan at a 7 Tesla machine as part of another research study. However, certain individuals cannot participate, including those with pacemakers, metal implants, or cochlear implants, as well as pregnant women or those who are claustrophobic. Participants will be asked about their experience of dizziness and vertigo during the MRI entrance and exit. This trial aims to make MRI scans more comfortable for those who may be affected by these sensations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants who will be undergoing an MRI scan at a 7 Tesla MRI.
- Exclusion Criteria:
- • Exclusion criteria include pacemaker, defibrillator wires, metal implants, cochlear implants, or ferromagnetic surgical clips in the brain.
- • Pregnancy
- • Claustrophobia occurs in perhaps 5% of patients, and they will not proceed with the test. All subjects will fill out the routine pretesting MRI questionnaire.
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Bryan Ward, MD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported